Browse Related Topics For:

Off-Label Use

89
Pharmaceutical Industry
75
FDA
66
Off-Label Promotion
42
First Amendment
41
Prescription Drugs
37
FDCA
33
Free Speech
26
Medical Devices
23
Commercial Speech
22
Marketing
16
Amarin
16
False Claims Act (FCA)
16
Misbranding
13
Healthcare
10
DOJ
10
Failure To Warn
9
FDA Approval
9
Qui Tam
8
Manufacturers
8
Preemption
7
Health Care Providers
7
Physicians
7
Whistleblowers
6
Labeling
6
Medicare
6
Negligence
6
Popular
6
Preliminary Injunctions
5
Caronia
5
False Advertising
5
Fraud
5
FTC
5
Product Labels
4
Birth Defects
4
Compliance
4
Criminal Prosecution
4
First-to-File
4
GlaxoSmithKline
4
Hospitals
4
Product Defects
4
Relators
3
Advertising
3
Appeals
3
Breach of Warranty
3
CMS
3
Comment Period
3
Corporate Counsel
3
FDA Warning Letters
3
Financial Conduct Authority (FCA)
3
Generic Drugs
3
Healthcare Fraud
3
Medicaid
3
Misrepresentation
3
Patents
3
Public Health
3
SCOTUS
3
Summary Judgment
2
Abbott Laboratories
2
Bristol-Myers Squibb
2
Causation
2
Choice-of-Law
2
Citizen Petitions
2
Class Action
2
Clinical Trials
2
Declaratory Relief
2
Dietary Supplements
2
Dismissals
2
Draft Guidance
2
Due Process
2
Enforcement Actions
2
EU
2
Expert Testimony
2
Expert Witness
2
Federal Register
2
Fines
2
Fraudulent Concealment
2
FTC Act
2
HHS
2
Injunctive Relief
2
Innovator Liability
2
InterMune
2
Johnson & Johnson
2
Kickbacks
2
Lanham Act
2
Life Sciences
2
Medical Research
2
Medicare Part D
2
Medtronic
2
Misleading Statements
2
Novartis
2
Omnicare
2
Orphan Drugs
2
Payor Contracts
2
Physician Medicare Reimbursements
2
Pleading Standards
2
Proposed Regulation
2
Public Hearing
2
Public Meetings
2
RICO
2
SEC
2
Standard of Care
2
Standing
2
Takeda Pharmaceuticals
2
Third-Party
2
Trademarks
2
Zofran
1
3D Printing
1
510(k) RTA
1
Administrative Procedure Act
1
Admissible Evidence
1
Adverse Events
1
Affordable Care Act
1
Agency Deference
1
Allergan Inc
1
Alzheimer's
1
Amazon
1
Amended Regulation
1
America Invents Act
1
Amicus Briefs
1
ANDA
1
Animal Drugs
1
Anti-Kickback Statute
1
Arbitration
1
Attorney Generals
1
Attorney-Client Privilege
1
Below-Cost Pricing
1
Benefit Plan Sponsors
1
Biologics
1
Biotechnology
1
Board of Directors
1
CA Supreme Court
1
Calculation of Damages
1
Cancer
1
Celebrity Endorsements
1
Cephalon
1
Certiorari
1
Chilling Effect
1
Civil Conspiracy
1
Civil Monetary Penalty
1
Class Certification
1
Class Representatives
1
CLRA
1
Commercial Marketing
1
Common Law Claims
1
Communications Decency Act
1
Compelled Speech
1
Compensatory Damages
1
Conflicting Proposals
1
Consent
1
Constitutional Challenges
1
Contract Drafting
1
COPPA
1
Copyright
1
Corporate Criminal Fines
1
Corporate Officers
1
Criminal Investigations
1
Cybertheft
1
Data Brokers
1
Data Privacy
1
Data Protection
1
Data Security
1
Daubert Standards
1
De Novo Standard of Review
1
Declaratory Judgments
1
Defamation
1
Design Defects
1
Disclaimers
1
Discovery
1
Discovery Rule
1
Diversity Jurisdiction
1
DMEPOS
1
Do Not Disturb
1
Drug Approvals
1
Due Diligence
1
Duty of Care
1
E-Cigarettes
1
Electronic Communications
1
Eleventh Amendment
1
Enforcement
1
EPA
1
ESPN
1
Ethics
1
Evidence Suppression
1
Ex Post Facto Clause
1
Facebook
1
Fair Notice
1
False Statements
1
FCC
1
Federal Contractors
1
Federal Question Jurisdiction
1
Federal v State Law Application
1
FERA
1
FFDCA
1
FIFRA
1
Fifth Amendment
1
Final Rules
1
Financial Services Authority
1
Forfeiture Statutes
1
Form 10-K
1
Former Employee
1
Fourteenth Amendment
1
Fraudulent Joinder
1
FRCP 23(b)(3)
1
FTC v Actavis
1
General Jurisdiction
1
Genetically Engineered Seed
1
Genuine Issue of Material Fact
1
Good Faith
1
Government Investigations
1
GRAS
1
Halliburton
1
Hatch-Waxman
1
HCEI
1
Healthcare Facilities
1
Healthcare Reform
1
Hearsay
1
Heightened Scrutiny
1
HIPAA
1
Hospital Mergers
1
HRSA
1
Human Rights
1
Humana
1
Implied Certification
1
Implied Preemption
1
Implied Warranties
1
Indictments
1
Induced Infringement
1
Inducements
1
Informed Consent
1
Insider Trading
1
Instagram
1
Insurance Industry
1
International Arbitration
1
Interstate Commerce
1
Investigational New Drug Application (IND)
1
Ireland
1
Jury Verdicts
1
Kaplan
1
Kim Kardashian
1
Learned Intermediary
1
Licenses
1
Lipitor
1
Long Term Care Facilities
1
Marijuana
1
Mary Jo White
1
Mass Tort Litigation
1
Medical Expenses
1
Medical Negligence
1
Mensing
1
Merck
1
Midnight Rules Relief
1
Morgan Stanley
1
Motion to Dismiss
1
Motion to Remand
1
MySpace
1
Negligence Per Se
1
Negligent Infliction of Emotional Distress
1
Negligent Misrepresentation
1
Nexus
1
NLRA
1
Northern Ireland
1
Obama Administration
1
Out-of-State Judgments
1
Overpayment
1
Par Pharmaceutical
1
Patent Infringement
1
Patent Litigation
1
Patent Reform
1
Payday Loans
1
Peer Review
1
Pending Legislation
1
Pensions
1
Personal Jurisdiction
1
Personal Liability
1
Personally Identifiable Information
1
Pesticides
1
Petition For Rehearing
1
Pfizer
1
Pharmaceutical Patents
1
Pharmacies
1
PHRMA
1
Ponzi Scheme
1
Predominance Requirement
1
Prescription Drug Coverage
1
Prior User
1
Prisoners
1
Promissory Estoppel
1
Prompt Payment
1
Public Disclosure
1
Public Safety
1
Punitive Damages
1
Putative Class Actions
1
Reed v Town of Gilbert
1
Registration
1
Regulatory Standards
1
Remand
1
Required Communications
1
Res Ipsa Loquitur
1
Retailers
1
Rule 23
1
Rule 26
1
Rule 9(b)
1
Rulemaking Process
1
Schering-Plough
1
Scientific Evidence
1
Scientific Research
1
Search Warrant
1
Section 340B
1
Section 5
1
Securities Act of 1933
1
Self-Authentication
1
Settlement
1
Skilled Nursing Facility
1
Skinnygirl Margarita
1
Social Media
1
Sovereign Immunity
1
Split of Authority
1
Spoliation
1
Statute of Limitations
1
Statutory Immunity
1
Strict Liability
1
Subject Matter Jurisdiction
1
Subpoenas
1
Subsequent Remedial Measures
1
TCPA
1
Technology
1
Testimony
1
The Common Rule
1
Third Party Funding
1
Tobacco
1
Tortious Interference
1
Transfer of Venue
1
Transition Team
1
Trump Administration
1
Twitter
1
Twombly/Iqbal Pleading Standard
1
Unfair Competition
1
Unfair or Deceptive Trade Practices
1
USDA
1
Virtual Goods
1
Warning Labels
1
Wells Fargo
1
Whistleblower Protection Policies
1
White Collar Crimes
1
Wire Fraud
1
Work Product Privilege
1
WSLA
1
Yates Memorandum
1
Young Lawyers
1
YouTube
Feedback? Tell us what you think of the new jdsupra.com!